| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/22/2003 | US6596539 Modification of virus tropism and host range by viral genome shuffling |
| 07/22/2003 | US6596536 Monoclonal antibody for use in the treatment and diagnosis of autoimmune and arthritic diseases |
| 07/22/2003 | US6596529 Manipulation of negative stranded RNA viruses by rearrangement of their genes and uses thereof |
| 07/22/2003 | US6596526 Furin polypeptides with improved characteristics |
| 07/22/2003 | US6596515 Insulin gene amplified from human genomic DNA by use of a pair of insulin primers and a K14 promoter gene amplified by use of a pair of K14 primers inserted together into pUChsneo |
| 07/22/2003 | US6596512 Nucleotide sequence coding nematode dopamine transport protein for use as tool in prevention and treatment of parasitic infection; for use in treatment of psychological disorders |
| 07/22/2003 | US6596511 Methods of refolding proteins |
| 07/22/2003 | US6596510 Secretion of carrier-bound proteins into the periplasma and the extracellular space |
| 07/22/2003 | US6596509 Expression vector for use as gene transfer tool in genetic engineering |
| 07/22/2003 | US6596508 Plasmid for use in te expressing of heterologous proteins |
| 07/22/2003 | US6596498 Bone stimulating factor |
| 07/22/2003 | US6596495 EGL-1, a new protein required for programmed cell death in C. elegans that interacts with the BCL-2-like protein CED-9 |
| 07/22/2003 | US6596491 Tenascin-C nucleic acid ligands |
| 07/22/2003 | US6596490 Nucleotide sequence capable of forming hairpin loops for use as tools in hybridization analysis |
| 07/22/2003 | US6596488 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of cancer |
| 07/22/2003 | US6596485 Fusion proteins capapble of presenting the peptide in a conformationally restricted form; use in screening peptide libraries |
| 07/22/2003 | US6596482 Nucleic acids encoding BAZ1α transcriptional regulator and methods of use |
| 07/22/2003 | US6596478 Detecting zoonotic infection in a xenograft recipient; obtain fluid sample, incubate with antibody, detect formation of an antigen/antibody complex, presence of complex indicates presence of infective agent |
| 07/22/2003 | US6596476 Kit for use in detection of viral diseases |
| 07/22/2003 | US6596475 Protein conjugates containing multimers of green fluorescent protein |
| 07/22/2003 | US6596473 Detection of antiapotosis protein; obtain genetically engineered cells, measure viable cells, incubate with antiapoptosis agent, compare with control, evaluate adjustment in apoptosis activity |
| 07/22/2003 | US6596281 Mycobacterium tuberculosis specific proteins and genes, mixtures of antigens and uses thereof |
| 07/22/2003 | US6596280 Live bimavirus such as infectious bursal disease virus |
| 07/22/2003 | US6596279 Immunodeficiency recombinant poxvirus |
| 07/22/2003 | US6596277 Methods of decreasing cell adhesion |
| 07/22/2003 | US6596269 Methods of treating chronic pain |
| 07/22/2003 | CA2329473C Dna encoding prostaglandin receptor ep1 |
| 07/22/2003 | CA2229775C Recombinant conglutinin and producing method thereof |
| 07/22/2003 | CA2220515C Process for producing erythropoietin containing no animal proteins |
| 07/22/2003 | CA2109320C Peptide nucleic acids |
| 07/22/2003 | CA2033085C Use of vaccine preparations containing adenyl cyclase or adenyl cyclase producing bacteria as protecting antigens against bordetella effects |
| 07/17/2003 | WO2003058248A2 Diagnostics and vaccines for mycrobacterium paratuberculosis infections |
| 07/17/2003 | WO2003058233A1 Method of screening compound having fungal cell wall synthesis inhibitory activity |
| 07/17/2003 | WO2003058203A2 Extended glucagon-like peptide-1 analogs |
| 07/17/2003 | WO2003058021A2 Novel apoptosis-inducing dna sequences |
| 07/17/2003 | WO2003057926A1 Gene products differentially expressed in cancerous breast cells and their methods of use |
| 07/17/2003 | WO2003057920A1 Drug response marker in beta-1 adrenergic receptor gene |
| 07/17/2003 | WO2003057917A2 An isolated nucleotide sequence responsible for the tomato dark green (dg) mutation and uses thereof |
| 07/17/2003 | WO2003057911A2 Single nucleotide polymorphisms predicting cardiovascular disease and medication efficacy |
| 07/17/2003 | WO2003057907A1 Expression and purification of atm protein using vaccinia virus |
| 07/17/2003 | WO2003057900A2 Pseudomonas virulence factors and uses thereof |
| 07/17/2003 | WO2003057899A2 Ion transporter stress-related polypeptides and methods of use in plants |
| 07/17/2003 | WO2003057892A2 Viruses with enhanced lytic potency |
| 07/17/2003 | WO2003057885A1 Hiv-1 virus tat-protein mutants |
| 07/17/2003 | WO2003057884A1 Human serum albumin-timp2 fusion protein, a polynucleotide encoding the same and a method of producing the human serum albumin-timp2 fusion protein |
| 07/17/2003 | WO2003057883A1 The human hepatoma-derived growth factor 5, its coding sequence, the method of producing it and the uses of it |
| 07/17/2003 | WO2003057881A1 Method of stabilizing protein |
| 07/17/2003 | WO2003057878A1 INDUCTION OF THE FORMATION OF INSULIN-PRODUCING CELLS VIA GENE TRANSFER OF PANCREATIC β-CELL-ASSOCIATED TRANSCRIPTIONAL FACTOR |
| 07/17/2003 | WO2003057877A1 Characteristic base sequences occurring in plant genes and method of utilizing the same |
| 07/17/2003 | WO2003057866A1 Dhfr-deficient cho cell line transfected with an anti-apoptotic gene, method for preparation thereof, and method for producing target protein using the same |
| 07/17/2003 | WO2003057864A1 Transgenic papp-a non-human mammals |
| 07/17/2003 | WO2003057859A2 Genes for altering mitochondrial function and for hybrid seed production |
| 07/17/2003 | WO2003057856A2 Dominant negative proteins and methods thereof |
| 07/17/2003 | WO2003057854A2 Novel proteins and nucleic acids encoding same |
| 07/17/2003 | WO2003057852A2 Purification and characterization of hla proteins |
| 07/17/2003 | WO2003057851A2 Binding proteins as biosensors |
| 07/17/2003 | WO2003057847A2 METHODS AND MATERIALS FOR MODULATING ENaC-BETA |
| 07/17/2003 | WO2003057834A2 Expression of protective antigens in transgenic chloroplasts and the production of improved vaccines |
| 07/17/2003 | WO2003057833A2 Mutant chromophores/fluorophores and methods for making and using the same |
| 07/17/2003 | WO2003057831A2 Dtat fusion toxin |
| 07/17/2003 | WO2003057830A2 Compositions and methods for hydroxylating epothilones |
| 07/17/2003 | WO2003057827A2 Insulin-responsive dna binding protein-1 and methods to regulate insulin-responsive genes |
| 07/17/2003 | WO2003057825A2 Gene expression patterns in response to atypical and typical neuroleptic agents in the central nervous system |
| 07/17/2003 | WO2003057824A2 Compositions and methods for the inhibition of membrane fusion by paramyxoviruses |
| 07/17/2003 | WO2003057823A2 Epitope synchronization in antigen presenting cells |
| 07/17/2003 | WO2003057821A2 Mut-il-18 or mut-il-18r proteins, antibodies, compositions, methods and uses |
| 07/17/2003 | WO2003057820A2 Peptide activators of vegf |
| 07/17/2003 | WO2003057734A1 Entrapped binding proteins as biosensors |
| 07/17/2003 | WO2003057733A1 Antibodies against fibroblast growth factor 23 |
| 07/17/2003 | WO2003057731A2 Human pheromone receptors |
| 07/17/2003 | WO2003057730A1 Ligand for g-protein coupled receptor gpr43 and uses thereof |
| 07/17/2003 | WO2003057729A2 Mammal prolactin variants |
| 07/17/2003 | WO2003057728A1 A novel splice variant of myd88 and uses thereof |
| 07/17/2003 | WO2003057727A1 Methods of producing silk polypeptides and products thereof |
| 07/17/2003 | WO2003057726A1 Cytotoxic cyplasin of the sea hare, Aplysia punctata, cDNA cloning and expression of bioreactive recombinants |
| 07/17/2003 | WO2003057725A2 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 07/17/2003 | WO2003057720A2 Recovery of biofilament proteins from biological fluids |
| 07/17/2003 | WO2003057719A2 Methods of modulating localization and physiological function of ip3 receptors |
| 07/17/2003 | WO2003057712A2 Humanized lactoferrin and uses thereof |
| 07/17/2003 | WO2003057711A2 Isolated cytokine receptor licr-2 |
| 07/17/2003 | WO2003057708A2 Fusion proteins |
| 07/17/2003 | WO2003057257A1 Cc10 inhibits th2 cytokines and eotaxins involved in allergic diseases |
| 07/17/2003 | WO2003057252A1 Human mast cell-expressed membrane proteins |
| 07/17/2003 | WO2003057240A2 Treatment and diagnosis of af4-dependant diseases |
| 07/17/2003 | WO2003057236A1 Body weight gain inhibitor |
| 07/17/2003 | WO2003057178A2 Viral capsid assembly intermediates |
| 07/17/2003 | WO2003057174A2 Methods and compositions for protein expression and purification |
| 07/17/2003 | WO2003057168A2 Cancer-associated epitope |
| 07/17/2003 | WO2003057158A2 Method of treating apoptosis and compositions thereof |
| 07/17/2003 | WO2003057156A2 Epithelial cell lines from gene knockout mice and methods of use thereof |
| 07/17/2003 | WO2003057152A2 Hair follicle growth |
| 07/17/2003 | WO2003057146A2 Novel compositions and methods for cancer |
| 07/17/2003 | WO2003057134A2 Specific binding agents of human angiopoietin-2 |
| 07/17/2003 | WO2003057130A2 Common lymphatic endothelial and vascular endothelial receptor-1 (clever-1) and uses thereof |
| 07/17/2003 | WO2003056914A1 Methods to engineer mammalian-type carbohydrate structures |
| 07/17/2003 | WO2003056913A1 Nonhuman model animal lacking the ability to control lymphocyte migration |
| 07/17/2003 | WO2003047507A3 Factor viii c2 domain variants |
| 07/17/2003 | WO2003046172A3 Alzheimer’s disease model |
| 07/17/2003 | WO2003038057A3 Genetic vaccine against human immunodeficiency virus |
| 07/17/2003 | WO2003035892A3 Novel methods for introducing molecules into cells and vectors and compositions for use in such methods |